This aligns with reported effects of RAD51 knockdown in other cancers—suppressing proliferation and promoting ROS accumulation in pancreatic cancer [11], inhibiting proliferation/migration/invasion in cervical squamous carcinoma [12] and impeding proliferation/migration/invasion while enhancing apoptosis/DNA damage in liver cancer [8]. The gene discussed is RAD51; the disease is liver cancer.